Marker | Function | References |
---|---|---|
AREG | Maintain immune cell function | [115] |
CCL2 | Recruit monocytes and macrophages | [116] |
CCL5 | Promote carcinogenesis | [117] |
CCL27 | Inhibit immune cell function | [118] |
CCN1 | Induce fibroblast senescence and restricts cutaneous fibrosis | [119] |
FGF4 | Embryonic development | [120] |
FGF8 | Embryonic development | [120] |
GM-CSF | Regulate tumor immunosuppression | [121] |
GRO | Promote tumor cells invasion | [115] |
HGF | Maintain the function of stem cells | [122] |
IFN-γ | Induce the activation of macrophages | [123] |
IGF-1 | Promote tumor cells invasion; Promote angiogenesis | [124] |
IGF-2 | Promote tumor cells invasion; Promote angiogenesis | [125] |
IGFBP-4 | Promote cellular senescence | [8] |
IGFBP-6 | Inhibit cellular senescence | |
IGFBP-7 | Promote cellular senescence | [127] |
IL-1 | Inhibit B lymphocyte formation; Involved in signaling pathways regulating SASP secretion; Lead inflammation and promote stem cell senescence | [128] |
IL-6 | Affect tumor cell invasion; Pluripotent stem cells; Lead to inflammation; Promote osteoclast function | |
IL-7 | Associated with B lymphocyte production; Beneficial to BMSCs function | [132] |
IL-8 | Promote tumor cells invasion | [7] |
MMP-1 | Accelerated osteogenic differentiation of BMSCs | [133] |
MMP-2 | Embryonic development; Promote angiogenesis | [134] |
MMP-3 | Extracellular matrix degradation and thinning of the fibrous cap in the artery | [135] |
MMP-9 | Degradation of extracellular matrix; Embryonic development | [136] |
MMP-13 | Promote tumor cells invasion; Promote angiogenesis | [137] |
PDGF-AA | Accelerated wound healing | [138] |
TGF-β | Promote angiogenesis; Promote BMSCs recruitment; Regulate the RANKL/OPG ratio | |
TNF-α | Lead to inflammation; Promote osteoclast function | |
VEGF | Promote angiogenesis | [142] |